Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Accenture
Julphar
Harvard Business School
AstraZeneca
Boehringer Ingelheim

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)

Docket   Try a Free Trial Date Filed 2017-01-17
Court District Court, N.D. West Virginia Date Terminated 2017-03-10
Cause 35:271 Patent Infringement Assigned To Irene Patricia Murphy Keeley
Jury Demand None Referred To
Parties MYLAN INC.; MYLAN PHARMACEUTICALS INC.; NATCO PHARMA LTD.; TEVA NEUROSCIENCE, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 9,402,874
Attorneys Crystal R. Canterbury; Daryl L. Wiesen; David L. Anstaett; David M. Hashmall; Elizabeth J. Holland; Gordon H. Copland; James F. Companion; John T. Bennett; Nicholas K. Mitrokostas; Shannon M Bloodworth; William G. James; William J O'Brien; Yolonda G. Lambert
Firms Daryl L. Wiesen; Goodwin Procter LLP; Goodwin Procter, LLP, the New York Times Building; John T. Bennett; Nicholas K. Mitrokostas; Perkins Coie LLC; Perkins Coie, LLP; Steptoe & Johnson PLLC - Bridgeport
Link to Docket External link to docket
Small Molecule Drugs cited in Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patent cited in this case is   Try a Free Trial .

Details for Teva Pharmaceuticals USA, Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-03-10 52 -of-treatment patent covering the product, U.S. Patent No. 9,402,874 (“the ‘874 patent”) (D. Del., Civ…prior to the expiration of U.S. Patent No. 9,155,775 (“the ‘775 patent”), which Teva claims is infringed… The United States Patent and Trademark Office issued the ‘775 patent to Teva Ltd. on October 13…infringing the ‘775 patent. Id. It contends that the processes of the ‘775 patent “are the only commercially… the ‘775 patent in the District of Delaware before Teva filed its suit on the ‘775 patent against them External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
QuintilesIMS
AstraZeneca
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.